Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Algae is a Japanese biotechnology and health-products company focused on spirulina-derived ingredients, organic germanium, natural pigments, and enzyme-related products. The company manufactures key products in-house and markets both consumer health products and business-to-business ingredients. Its operations include spirulina cultivation, extraction of natural blue and yellow pigments from spirulina, and GMP-certified manufacturing in Japan. Historically, the company evolved from Tokai Sangyo and changed its name to Japan Algae in 2003 as part of an overseas expansion strategy. The business appears to be primarily commercial rather than drug-development focused, with emphasis on nutrition, wellness, and functional bio-based ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Algae.